Medications

FDA approves Cobenfy for adults with schizophrenia

The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.

Cardiology

Causal relationship seen between GERD and hypertension

There is a positive causal relationship between gastroesophageal reflux disease (GERD) and hypertension, according to a study published online Sept. 23 in Frontiers in Cardiovascular Medicine.

page 2 from 19